Contents

Search

britumomab (Zevalin)

Mechanism of action: -> monoclonal antibody against CD20 Adverse effects: - severe cutaneous or mucocutaneous reactions, some with fatal outcome

Interactions

drug adverse effects of pharmaceutical monoclonal antibodies

General

pharmaceutical monoclonal antibody

References

  1. UniProt :accession P11836
  2. Medwatch http://www.fda.gov/medwatch/safety/2005/safety05.htm#Zevalin